SGLT2 inhibitors among patients with heart failure with preserved ejection fraction: A meta-analysis of randomised controlled trials.
Akash JaiswalVikash JaiswalSong Peng AngMuhammad HanifAnanya VadheraVibhor AgrawalTushar KumarAnagha M NairVamsikalyanReddy BorraVamsi GarimellaAngela IshakZarghoona WajidDavid SongAbdelrahman M AttiaHelen HuangVictor Hugo Aguilera AlvarezAbhigan Babu ShresthaMonodeep BiswasPublished in: Medicine (2023)
Our study finding shows that SGLT2 inhibitors significantly reduced the risk of first HF hospitalization or cardiovascular death and HF hospitalization; however, all-cause mortality was comparable between the groups.
Keyphrases